Docket Room.
HR 9559·Federal·house

IBOGAINE Act

In CommitteeFiled Jun 30, 2026
Sponsor: Rep. Luttrell, Morgan [R-TX-8] (R)
Latest Action

Referred to the Subcommittee on Health.

Jul 17, 2026

Email me when HR 9559 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HR 9559. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The IBOGAINE Act defines ibogaine, sets up a voucher program to reward developers of priority health drugs, and modifies the Right‑to‑Try and DEA quota rules to make schedule‑I psychedelics easier to study and prescribe. It also requires the VA to appoint a senior official, report on emerging therapies, and prepares the Attorney General to consider moving ibogaine to a lower schedule after successful Phase 3 trials.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HR 9559

3 free questions a day, no account

Sponsors

  • Rep. Luttrell, Morgan [R-TX-8] (R) · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HR 9559 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HR 9559 free

Or ask your AI assistant about HR 9559 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice